Yarrow Bioscience (YARW) Return on Sales (2017 - 2026)
Yarrow Bioscience's (YARW) quarterly Return on Sales came in at 0.0% in Q1 2026, little changed YoY from 0.0% in Q1 2025, and up 57.36% on a QoQ basis from 0.0% in Q2 2025.
Yarrow Bioscience (YARW) Return on Sales (2017 - 2026) Analysis & Trends
Yarrow Bioscience (YARW) has 10 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales advanced to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.75% in Q1 2022 to a low of 0.75% in Q4 2022.
- A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales soared 117 bps — and 2023, when it sank 75 bps.
- Tracing YARW's Return on Sales over 5 years: stood at 0.75% in 2022, then jumped by 99 bps to 0.0% in 2023, then surged by 80 bps to 0.0% in 2024, then grew by 17 bps to 0.0% in 2025, then surged by 57 bps to 0.0% in 2026.
- The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q2 2025), and 0.0% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 0.00% |
| 10 | Yarrow Bioscience | 31.43 Mn | 8.50 Mn | - | -0.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.05% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.75% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | 0.75% |
| Dec 31, 2021 | -0.12% |
| Sep 30, 2021 | -0.53% |
| Jun 30, 2021 | -0.31% |
| Mar 31, 2021 | -0.42% |